✨ Your Portfolio is fetched and updated from zerodha.
Small Chemicals
Market Cap
₹3,901 Cr.
P/E
28.67
About
Rossari Biotech Limited is a leading specialty chemicals manufacturing company in India, offering customized solutions to various industries such as FMCG, apparel, poultry, and animal feed. Their prod… Read more
Rossari Biotech Limited is a leading specialty chemicals manufacturing company in India, offer… Read more
Low
569
52W Range
High
973
  • Rossari Biotech
  • SH Kelkar & Co
  • Oriental Aromatics

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Verticals

Operational Metrics

    Select a Metric
    • Manufacturing Capacity - Speciality Chemicals (MTPA)
    • Capacity Utilization - Specilaity Chemicals (%)
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Rossari Biotech Ltd. Business

    Rossari Biotech Limited is a top specialty chemicals manufacturer in India, providing tailored solutions for FMCG, apparel, poultry, and animal feed industries with a wide product range encompassing home care, personal care, performance and textile specialty chemicals, as well as animal health products.

    Rossari Biotech major competitors are SH Kelkar & Co, Oriental Aromatics, Dynemic Products, Privi Speciality Che, Jocil, Clean Science, Atul.
    Market Cap of Rossari Biotech is ₹3,894 Crs.
    While the median market cap of its peers are ₹2,885 Crs.

    Rossari Biotech seems to be less financially stable compared to its competitors.
    Altman Z score of Rossari Biotech is 5.38 and is ranked 4 out of its 8 competitors.

    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec Dec Jun Sep
    Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec Feb Mar May Jun Aug Sep Dec Sep Dec Jun Aug
    Conference Call Mar Jun Sep Dec Mar Jun Sep Dec Mar Jun Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material